Rebecca Pellicano

Dr. Rebecca Pellicano is a Senior Lecturer at the School of Clinical Sciences at Monash Health, Monash University, where she contributes significantly to clinical research and medical education. Her work is deeply embedded in nephrology, rheumatology, and autoimmune diseases, with a focus on systemic lupus erythematosus, lupus nephritis, and drug-induced kidney injuries.

Her research interests span clinical medicine, particularly in the areas of autoimmune and inflammatory conditions affecting the kidneys, infection risks in immunocompromised patients, and medical student wellbeing. She employs both clinical case studies and epidemiological analyses to advance understanding in these fields.

The recent publication trends show a strong emphasis on systemic lupus erythematosus and its complications, including hospitalization risks and treatment responses. Additional work explores drug toxicities and broader issues in medical education, reflecting a dual commitment to patient care and training future clinicians.

• Scientific Awards: No specific awards mentioned in the provided text.

Dr. Pellicano has served as the Primary Chief Investigator on the long-running research project "Active CCRE in Renal Med (S/Ship)-Dr Pellicano" since 2004, indicating sustained grant funding and leadership in clinical research. While no formal advisees are listed, her collaborative publications suggest active mentorship and team-based research. She is involved in a multidisciplinary network including experts in rheumatology, nephrology, and infectious diseases.

Her research is conducted within the clinical and academic framework of Monash Health and Monash University, leveraging collaborations across departments and institutions to address complex clinical questions.